A 58-year-old postmenopausal woman presents with vaginal bleeding for 3 months. Pelvic examination reveals a normal-sized uterus. Transvaginal ultrasound shows an endometrial thickness of 12 mm with a heterogeneous echotexture. What is the most appropriate next step in management?

Explanation

## Clinical Approach to Abnormal Postmenopausal Bleeding ### Diagnostic Algorithm **Key Point:** Any postmenopausal bleeding warrants investigation. An endometrial thickness >5 mm on transvaginal ultrasound in a postmenopausal woman with bleeding is abnormal and requires tissue diagnosis. **High-Yield:** The gold standard for evaluating abnormal endometrial findings is direct visualization and tissue sampling via hysteroscopy with endometrial biopsy. This allows both visual assessment of the endometrium and histopathological diagnosis to exclude malignancy. ### Why Hysteroscopy with Biopsy is Correct 1. **Tissue diagnosis is mandatory** — Postmenopausal bleeding with thickened, heterogeneous endometrium has significant risk for endometrial cancer (up to 10–15% in this presentation). 2. **Hysteroscopy provides dual benefit** — Direct visualization of the endometrial cavity AND tissue sampling in one procedure. 3. **Sensitivity and specificity** — Hysteroscopic biopsy has >95% sensitivity for detecting endometrial pathology including malignancy [cite:Berek & Novak's Gynecology 16e Ch 39]. ### Differential Management Considerations | Finding | Endometrial Thickness | Next Step | |---------|----------------------|----------| | Postmenopausal bleeding | <5 mm, homogeneous | Reassurance, follow-up | | Postmenopausal bleeding | 5–10 mm, homogeneous | Hysteroscopy/biopsy OR endometrial sampling | | Postmenopausal bleeding | >10 mm OR heterogeneous | **Hysteroscopy with biopsy** (mandatory) | | Asymptomatic incidental finding | <5 mm | No further workup | **Clinical Pearl:** Heterogeneous echotexture is a red flag for malignancy and mandates tissue diagnosis regardless of exact thickness measurement. ### Why Other Options Are Incorrect - **Repeat ultrasound in 3 months** — Delays diagnosis in a patient with active bleeding and abnormal imaging. Unacceptable risk of missing cancer. - **MRI pelvis** — Staging tool, not diagnostic. Cannot be done before histological diagnosis is confirmed. - **Empirical hormonal therapy** — Masking potential malignancy with hormone therapy without tissue diagnosis is dangerous and violates oncologic principles.